BigTime Software Expands Executive Team to Accelerate AI Growth in PSA Software
The new leadership team will strengthen BigTime's professional services platform with AI-driven insights, smarter workflows, and faster time-to-value
In his new role as Chief Product Officer,
As SVP of Engineering,
"These hires come at a pivotal moment for BigTime," said CEO
"It's an exciting time to join BigTime," said Dube. "We're working with leaders whose top priorities are getting more efficient and accurate with quoting, staffing, invoicing, and every other aspect of project delivery, and the opportunities to embed AI into these workflows is enormous. On the product side, it's a dream—we have the tools to solve for a real need."
"BigTime already offers very nuanced, purpose-built solutions for professional services, and now we're layering in deeper data and new AI," said Hoffman. "The key is to make sure we're building from the right foundation. I look forward to strengthening BigTime's platform so customers can get the most out of these features while making sure the tools they already use stay strong and reliable."
About BigTime Software
BigTime is an AI‑powered platform for finance and operations leaders at professional services firms, including consulting, engineering, IT services, and accounting. It streamlines the entire client engagement lifecycle—from quoting and staffing to time tracking, invoicing, and reporting—helping nearly 3,000 firms boost profitability, accelerate cash flow, improve resource utilization, and gain real‑time visibility to scale with confidence.
Media Contact
+1-312-346-4646
View original content:https://www.prnewswire.com/news-releases/bigtime-software-expands-executive-team-to-accelerate-ai-growth-in-psa-software-302569737.html
SOURCE BigTime Software, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sabre Corporation Announces Early Tender Results of Previously Announced Cash Tender Offer and Consent Solicitation by Sabre Financial Borrower, LLC
- Skyworks Announces Extension of Expiration Date of Exchange Offers for Qorvo’s Senior Notes due 2029 and 2031
- Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share